Pathogenicity of clinical Acinetobacter baumannii isolates in a galleria mellonella host model according to blaOXA-40 gene and epidemiological outbreak status

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 2, 2014, Pages 1240-1242

  Esterly, John S ^a,b   McLaughlin, Milena M ^b,c   Malczynski, Michael ^b   Qi, Chao ^b,d   Zembower, Teresa R ^b,d   Scheetz, Marc H ^b,c  

^a CHICAGO STATE UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c MIDWESTERN UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLA OXA 40 GENE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; GALLERIA MELLONELLA; HUMAN; MORTALITY; NONHUMAN; PRIORITY JOURNAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; BETA-LACTAMASES; CHICAGO; DISEASE OUTBREAKS; GENE EXPRESSION; HUMANS; LARVA; MODELS, BIOLOGICAL; MOTHS; PLASMIDS; VIRULENCE;

EID: 84893456919     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02201-13     Document Type: Article

References (14)

1. Qi C, Scheetz MH, Malczynski M. 2009. Characterization of Acinetobacter baumannii genotypes recovered from patients with repeated colonization or infection. Diagn. Microbiol. Infect. Dis. 65:1-6. http://dx.doi.org/10.1016/j. diagmicrobio.2009.04.011.
2. Jander G, Rahme LG, Ausubel FM. 2000. Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J. Bacteriol. 182: 3843-3845. http://dx.doi.org/10.1128/JB.182.13.3843-3845.2000.
3. Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, Ausubel FM, Diener A. 2005. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect. Immun. 73:3842-3850. http://dx.doi.org/10.1128/IAI.73.7.3842-3850.2005.
4. Antunes LC, Imperi F, Carattoli A, Visca P. 2011. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One 6:e22674. http://dx.doi.org/10.1371/journal.pone.0022674.
5. Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC, Jr, Mylonakis E. 2009. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob. Agents Chemother. 53:2605-2609. http://dx.doi.org/10.1128/AAC.01533-08.
6. Esterly JS, Griffith M, Qi C, Malczynski M, Postelnick MJ, Scheetz MH. 2011. Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections. Antimicrob. Agents Chemother. 55:4844-4849. http://dx.doi.org/10.1128/AAC.01728- 10.
7. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing, p M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Qi C, Malczynski M, Parker M, Scheetz MH. 2008. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J. Clin. Microbiol. 46:1106-1109. http://dx.doi.org/10.1128/JCM.01877-07.
9. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
10. Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Nanas S, Markaki V, Vrettou C, Paniara O, Giamarellou H, Roussos C. 2010. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection 38:173-180. http://dx.doi.org/10.1007/s15010-010-0008-1.
11. Sheng WH, Liao CH, Lauderdale TL, Ko WC, Chen YS, Liu JW, Lau YJ, Wang LH, Liu KS, Tsai TY, Lin SY, Hsu MS, Hsu LY, Chang SC. 2010. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int. J. Infect. Dis. 14:e764-769. http://dx.doi.org/10.1016/j.ijid.2010.02.2254.
12. Paauw A, Caspers MP, Leverstein-van Hall MA, Schuren FH, Montijn RC, Verhoef J, Fluit AC. 2009. Identification of resistance and virulence factors in an epidemic Enterobacter hormaechei outbreak strain. Microbiology 155:1478-1488. http://dx.doi.org/10.1099/mic.0.024828-0.
13. Woods CW, Bressler AM, LiPuma JJ, Alexander BD, Clements DA, Weber DJ, Moore CM, Reller LB, Kaye KS. 2004. Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia. Clin. Infect. Dis. 38:1243-1250. http://dx.doi.org/10.1086/383313.
14. McLaughlin M, Malczynski M, Qi C, Barajas G, Radetski J, Zembower T, Scheetz MH. 2013. Virulence of vancomycin-resistant Enterococcus faecium according to linezolid resistance and clinical outbreak status. Antimicrob. Agents Chemother. 57:3923-3927. http://dx.doi.org/10.1128/AAC.00192-13.